All news articles

Dutch occupational-disease scheme to cover allergic lung disease from 2027

The Netherlands will add extrinsic allergic alveolitis to its occupational-disease compensation scheme from 1 January 2027. Eligible patients will be able to apply for a one-off payment of more than €27,000.

AI-generated editorial illustration based on the published article topic; not a documentary photograph.
Loading statistics…

People in the Netherlands with extrinsic allergic alveolitis will be able to apply for a one-off payment of more than €27,000 from 1 January 2027, under an expansion of the government’s scheme for occupational diseases caused by hazardous substances.

The disease, also known as hypersensitivity pneumonitis, involves inflammation of the air sacs in the lungs. The government says prolonged allergic reactions to substances such as mould or wheat allergens can cause it. Symptoms may include a flu-like feeling, coughing and breathlessness; scarring can also impair lung function.

Applications will be made through the Institute for Victims of Occupational Diseases caused by Hazardous Substances (ISBG). The payment is available to people with one of the listed occupational diseases who can demonstrate that they have it.

Extrinsic allergic alveolitis is the seventh disease added to the scheme, which has operated since 2023. It also covers allergic asthma and several cancers linked to workplace exposure, as well as CSE, or painters’ disease, and silicosis.

Sign in to give this article a thumbs up or down.

From the discussion

Private test discussion. Comments are readers’ views and are not yet automatically fact-checked. Editing is available for 60 seconds after posting.

Sign in with a confirmed reader account and choose a username to read comments and participate.

Sorting applies to top-level comments; replies remain oldest first. New comments and likes can change the order. Refresh for the current ranking.

Loading comments…